In the present study, we further explored the potential of Ad-shRRM1, this time in bladder cancer cells and found that Ad-shRRM1 effectively downregulated RRM1 expression, resulting in suppression of bladder cancer cell proliferation in vitro and in vivo. This evidence concerns the gene RRM1 and urinary bladder cancer.